CD30-directed Immunoconjugate

Accession Number

DBCAT003493

Description

Not Available

Drugs

Drug	Drug Description
Brentuximab vedotin	A CD30-directed antibody-drug conjugate used to treat various types of lymphoma.

Drugs & Drug Targets

Drug	Target	Type
Brentuximab vedotin	Tumor necrosis factor receptor superfamily member 8	target
Brentuximab vedotin	Cytochrome P450 3A4	enzyme
Brentuximab vedotin	ATP-binding cassette sub-family B member 5	transporter